BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21630256)

  • 1. Antibodies reactive to Plasmodium falciparum serine repeat antigen in children with Burkitt lymphoma from Ghana.
    Guech-Ongey M; Yagi M; Palacpac NM; Emmanuel B; Talisuna AO; Bhatia K; Stefan DC; Biggar RJ; Nkrumah F; Neequaye J; Tougan T; Horii T; Mbulaiteye SM
    Int J Cancer; 2012 Apr; 130(8):1908-14. PubMed ID: 21630256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endemic Burkitt lymphoma is associated with strength and diversity of Plasmodium falciparum malaria stage-specific antigen antibody response.
    Aka P; Vila MC; Jariwala A; Nkrumah F; Emmanuel B; Yagi M; Palacpac NM; Periago MV; Neequaye J; Kiruthu C; Tougan T; Levine PH; Biggar RJ; Pfeiffer RM; Bhatia K; Horii T; Bethony JM; Mbulaiteye SM
    Blood; 2013 Aug; 122(5):629-35. PubMed ID: 23645841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between IgG reactivity to Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) antigens and Burkitt lymphoma in Ghana and Uganda case-control studies.
    Derkach A; Otim I; Pfeiffer RM; Onabajo OO; Legason ID; Nabalende H; Ogwang MD; Kerchan P; Talisuna AO; Ayers LW; Reynolds SJ; Nkrumah F; Neequaye J; Bhatia K; Theander TG; Prokunina-Olsson L; Turner L; Goedert JJ; Lavstsen T; Mbulaiteye SM
    EBioMedicine; 2019 Jan; 39():358-368. PubMed ID: 30579868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High titers of IgG antibodies against Plasmodium falciparum serine repeat antigen 5 (SERA5) are associated with protection against severe malaria in Ugandan children.
    Okech B; Mujuzi G; Ogwal A; Shirai H; Horii T; Egwang TG
    Am J Trop Med Hyg; 2006 Feb; 74(2):191-7. PubMed ID: 16474069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of naturally acquired IgG antibodies against Plasmodium falciparum serine repeat antigen-5 with reduced placental parasitemia and normal birth weight in pregnant Ugandan women: a pilot study.
    Owalla TJ; Palacpac NM; Shirai H; Horii T; Egwang TG
    Parasitol Int; 2013 Jun; 62(3):237-9. PubMed ID: 23395684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase 1b randomized trial and follow-up study in Uganda of the blood-stage malaria vaccine candidate BK-SE36.
    Palacpac NM; Ntege E; Yeka A; Balikagala B; Suzuki N; Shirai H; Yagi M; Ito K; Fukushima W; Hirota Y; Nsereko C; Okada T; Kanoi BN; Tetsutani K; Arisue N; Itagaki S; Tougan T; Ishii KJ; Ueda S; Egwang TG; Horii T
    PLoS One; 2013; 8(5):e64073. PubMed ID: 23724021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural antibody responses to Plasmodium falciparum MSP3 and GLURP(R0) antigens are associated with low parasite densities in malaria patients living in the Central Region of Ghana.
    Amoah LE; Nuvor SV; Obboh EK; Acquah FK; Asare K; Singh SK; Boampong JN; Theisen M; Williamson KC
    Parasit Vectors; 2017 Aug; 10(1):395. PubMed ID: 28835262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural human immunoglobulin G subclass responses to Plasmodium falciparum serine repeat antigen in Uganda.
    Okech BA; Nalunkuma A; Okello D; Pang XL; Suzue K; Li J; Horii T; Egwang TG
    Am J Trop Med Hyg; 2001 Dec; 65(6):912-7. PubMed ID: 11791998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody levels to multiple malaria vaccine candidate antigens in relation to clinical malaria episodes in children in the Kasena-Nankana district of Northern Ghana.
    Dodoo D; Atuguba F; Bosomprah S; Ansah NA; Ansah P; Lamptey H; Egyir B; Oduro AR; Gyan B; Hodgson A; Koram KA
    Malar J; 2011 May; 10():108. PubMed ID: 21529376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgG antibody response against Plasmodium falciparum aminopeptidase 1 antigen in Gabonese children living in Makokou and Franceville.
    Oyegue-Liabagui SL; Imboumy-Limoukou RK; Kouna CL; Bangueboussa F; Schmitt M; Florent I; Lekana-Douki JB
    Clin Exp Immunol; 2020 Jun; 200(3):287-298. PubMed ID: 32027020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness.
    Stanisic DI; Richards JS; McCallum FJ; Michon P; King CL; Schoepflin S; Gilson PR; Murphy VJ; Anders RF; Mueller I; Beeson JG
    Infect Immun; 2009 Mar; 77(3):1165-74. PubMed ID: 19139189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of IPTp on Plasmodium falciparum antibody levels among pregnant women and their babies in a sub-urban coastal area in Ghana.
    Stephens JK; Kyei-Baafour E; Dickson EK; Ofori JK; Ofori MF; Wilson ML; Quakyi IA; Akanmori BD
    Malar J; 2017 May; 16(1):224. PubMed ID: 28549426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of the profiles of IgG subclass-specific responses to Plasmodium falciparum apical membrane antigen-1 and merozoite surface protein-1 in naturally exposed individuals living in malaria hypoendemic settings, Iran.
    Rouhani M; Zakeri S; Mehrizi AA; Djadid ND
    Malar J; 2015 Feb; 14():58. PubMed ID: 25652589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breadth of Functional Antibodies Is Associated With Plasmodium falciparum Merozoite Phagocytosis and Protection Against Febrile Malaria.
    Kana IH; Singh SK; Garcia-Senosiain A; Dodoo D; Singh S; Adu B; Theisen M
    J Infect Dis; 2019 Jun; 220(2):275-284. PubMed ID: 30820557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmodium falciparum merozoite surface antigen-specific cytophilic IgG and control of malaria infection in a Beninese birth cohort.
    Adamou R; Dechavanne C; Sadissou I; d'Almeida T; Bouraima A; Sonon P; Amoussa R; Cottrell G; Le Port A; Theisen M; Remarque EJ; Longacre S; Moutairou K; Massougbodji A; Luty AJF; Nuel G; Migot-Nabias F; Sanni A; Garcia A; Milet J; Courtin D
    Malar J; 2019 Jun; 18(1):194. PubMed ID: 31185998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral immune response to Plasmodium falciparum vaccine candidate GMZ2 and its components in populations naturally exposed to seasonal malaria in Ethiopia.
    Mamo H; Esen M; Ajua A; Theisen M; Mordmüller B; Petros B
    Malar J; 2013 Feb; 12():51. PubMed ID: 23383869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, laboratorial and immunological aspects of severe malaria in children from Guinea-Bissau.
    Domingos J; Casimiro A; Portugal-Calisto D; Varandas L; Nogueira F; Silva MS
    Acta Trop; 2018 Sep; 185():46-51. PubMed ID: 29684356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquisition of antibodies against Plasmodium falciparum merozoites and malaria immunity in young children and the influence of age, force of infection, and magnitude of response.
    Stanisic DI; Fowkes FJ; Koinari M; Javati S; Lin E; Kiniboro B; Richards JS; Robinson LJ; Schofield L; Kazura JW; King CL; Zimmerman P; Felger I; Siba PM; Mueller I; Beeson JG
    Infect Immun; 2015 Feb; 83(2):646-60. PubMed ID: 25422270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burkitt lymphoma expresses oncofetal chondroitin sulfate without being a reservoir for placental malaria sequestration.
    Agerbaek MØ; Pereira MA; Clausen TM; Pehrson C; Oo HZ; Spliid C; Rich JR; Fung V; Nkrumah F; Neequaye J; Biggar RJ; Reynolds SJ; Tosato G; Pullarkat ST; Ayers LW; Theander TG; Daugaard M; Bhatia K; Nielsen MA; Mbulaiteye SM; Salanti A
    Int J Cancer; 2017 Apr; 140(7):1597-1608. PubMed ID: 27997697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fc gamma receptor IIa (CD32) polymorphism and antibody responses to asexual blood-stage antigens of Plasmodium falciparum malaria in Sudanese patients.
    Nasr A; Iriemenam NC; Troye-Blomberg M; Giha HA; Balogun HA; Osman OF; Montgomery SM; ElGhazali G; Berzins K
    Scand J Immunol; 2007 Jul; 66(1):87-96. PubMed ID: 17587350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.